T he CD8ϩ T cells are the prime mediators of adaptive immunity against a number of intracellular parasites, bacteria, and viruses. In rodent models of malaria parasite infection, CD8ϩ T cells induced after immunization with sporozoites play a major role in protective immunity, inhibiting the development of the liver stages of these parasites. Adoptive transfer of CD8ϩ T cell clones specific for epitopes expressed in sporozoite and liver stages strongly inhibits the intracellular development of parasites (1-3). Moreover, CD8ϩ T cells induced by immunization with subunit vaccines expressing these plasmodial antigens can also abolish the intrahepatocytic development of these parasites and prevent the occurrence of blood infections (4-8).
T
he CD8ϩ T cells are the prime mediators of adaptive immunity against a number of intracellular parasites, bacteria, and viruses. In rodent models of malaria parasite infection, CD8ϩ T cells induced after immunization with sporozoites play a major role in protective immunity, inhibiting the development of the liver stages of these parasites. Adoptive transfer of CD8ϩ T cell clones specific for epitopes expressed in sporozoite and liver stages strongly inhibits the intracellular development of parasites (1) (2) (3) . Moreover, CD8ϩ T cells induced by immunization with subunit vaccines expressing these plasmodial antigens can also abolish the intrahepatocytic development of these parasites and prevent the occurrence of blood infections (4) (5) (6) (7) (8) .
Studies in humans living in malaria-endemic areas indicate that the CD8ϩ T cell responses to liver stages are rather restricted because they are usually found at very low levels, even in individuals living in regions with intense malaria transmission (9, 10) . This phenomenon has been attributed to the existence of altered peptide ligands resulting from polymorphisms present in epitopes recognized by CD8ϩ T cells, which could induce antagonistic effects that may interfere with T cell priming and the survival of memory cells (11, 12) . The situation found in human populations is not entirely different from that observed in experimental rodent models. Immunization of mice with Plasmodium yoelii sporozoites induces rather low CD8ϩ T cell responses, barely detectable by highly sensitive ex vivo assays such as the enzyme immunospot assay (ELISPOT) (7, 13, 14) .
The reduced magnitude of primary CD8ϩ T cell responses observed in normal mice does not appear to be caused by a low immunogenicity of sporozoites. In fact, recent studies indicate that immunization with malaria sporozoites induces a strong and swift activation of naïve CD8ϩ T cell precursors. Using transgenic (Tg) mice bearing a T cell receptor specific for the SYVPSAEQI epitope from the P. yoelii circumsporozoite protein, we demonstrated that within 24 h of immunization, naïve CD8ϩ T cells already express effector functions, such as the production of IFN␥ and perforin and the capacity to eliminate liver-stage parasites (15) . Whereas the initiation of this T cell differentiation and proliferation appears to be driven only by antigen, IL-4-secreting CD4ϩ T cells are crucial to sustain the developing CD8ϩ T cell response (16) .
To identify and characterize the underlying mechanisms influencing the magnitude and efficiency of primary CD8ϩ T cell responses against malaria liver stages, we evaluated the role played by antigen in the modulation and maintenance of these responses. Although it is established that sporozoite immunization induces the activation of antigen-specific CD8ϩ T cells, it is not known how long antigen presentation lasts and, more important, how long this antigen presentation functions to induce the activation of CD8ϩ T cells. Here we report studies aimed at estimating the duration of functional in vivo antigen presentation after sporozoite immunization as determined by measuring the activation of antigen-specific CD8ϩ T cell precursors. We also investigated the effect of prolonged antigen presentation and its effect on the magnitude of primary CD8ϩ T cell responses. Understanding these issues should aid in the design of vaccines not only against malaria but also for other microbial diseases.
Materials and Methods
Mice and Parasites. Six-to eight-week-old female CB6F1 and RAG2 Ϫ/Ϫ B10D2 mice were obtained from the National Cancer Institute and The Jackson Laboratory, respectively. The generation of the SYVPSAEQI-specific T cell receptor Tg mice has been described previously (15) . P. yoelii 17XNL parasites were maintained as described (2) . Sporozoites were collected by dissecting the salivary glands of infected Anopheles stephensi mosquitoes Ϸ2 weeks after an infective blood meal. spleen cells isolated from normal syngenic mice in addition to the Tg cells. Immunizations with sporozoites were performed by i.v. injection of 3-5 ϫ 10 4 radiation-attenuated (␥-source, 20 krad) sporozoites or otherwise specified in the figure legends. Infection via bites of irradiated infected mosquitoes was performed as described (17, 18) . To generate activated͞memory cells, mice that received Tg cells were immunized i.v. with a recombinant vaccinia virus (recVAC, 1 ϫ 10 6 pfu per mouse) expressing the SYVPSAEQI epitope (4, 19) . Primaquine (Sigma) was administered s.c. (60 mg͞kg) as described (20) . of Health tetramer facility or prepared as described (21, 22) . Fluorescent-labeled mAb to mouse CD8␣ (53-6.7) were obtained from PharMingen. Staining of cells for FACS analysis was performed by using standard protocols after blocking with unconjugated streptavidin (Molecular Probes) and F C block (PharMingen). Cells were analyzed by using FACSCALIBUR and CELL QUEST software (Becton Dickinson). Between 200,000 and 500,000 live events are usually acquired.
ELISPOT Assay and Cell Culture. The ex vivo IFN␥ ELISPOT to enumerate the number of SYVPSAEQI-specific CD8ϩ T cells was performed as described (14) . MHC-compatible A20.2J target cells were coated with the SYVPSAEQI peptide and were incubated with mouse lymphocytes for 20-24 h. Anti-mouse IFN␥ (R4) and biotinylated anti-mouse IFN␥ (XMG1.2) were obtained from PharMingen.
Results

Short-Term Antigen Presentation Defines the Magnitude of the CD8؉
T Cell Response Against Malaria Liver Stages. In previous studies, by using an adoptive transfer system with Tg CD8ϩ T cells specific for the SYVPSAEQI epitope of the P. yoelii circumsporozoite protein, we determined that the activation of CD8ϩ T cells and the development of their antiparasitic functions are detectable as early as 24 h after immunization. This T cell response reaches the highest magnitude on day 4, suffers a major contraction between days 6 and 7, and becomes stabilized after day 8 (15) . After this initial phase, the response remains unchanged in the spleen and liver for at least 6 months (Fig. 1) . These studies indicate that a single immunization drives naïve CD8ϩ T cells to undergo differentiation, proliferation, and later on, long-term persistence.
These results raised the question regarding the length of time of in vivo antigen presentation and the influence that it may have on the generation and maintenance of CD8ϩ T cell memory. In studies with other microbial systems, this matter has been investigated by using activated͞memory T cells obtained from immunized mice that were transferred to naïve mice to evaluate the long-term maintenance of memory CD8ϩ T cells in the absence of antigen. This approach, however, has been criticized as it cannot rule out the possibility that in addition to the CD8ϩ T cells obtained from immunized mice, antigen or antigenbearing cells are also being transferred (23-29).
In view of this situation, and taking advantage of the specificity and sensitivity of the Tg CD8ϩ T cell system, we developed an approach to estimate the duration of in vivo antigen presentation. In this system, mice were injected with attenuated sporozoites, and at different time points after immunization, they received naïve Tg CD8ϩ T cells. Four days after the transfer of T cells into immunized mice, we evaluated the number as well as the differentiation status of the CD8ϩ T cells in the spleen and liver by using ELISPOT and flow cytometry with SYVPSAEQI tetramers. We found that in the spleen, maximum numbers of SYVPSAEQI-specific IFN␥-secreting CD8ϩ T cells were observed when the Tg CD8ϩ cells were transferred at the same time as sporozoite immunization ( Figs. 2A Left and 3A) . The number of activated cells decreased by Ϸ10-20% when transfer was performed 8 h later and was further reduced by Ϸ60 and 85% when the Tg cells were transferred 24 and 48 h after immunization, respectively. CD8ϩ T cells transferred 96 h after immunization or later (data not shown) showed negligible activation levels, comparable to control-immunized mice that did not receive Tg cells. Importantly, the same results were obtained when the magnitude of the CD8ϩ T cell response was evaluated by flow cytometry by using SYVPSAEQI-specific tetramers (Fig. 2B ). We also assessed the response of T cells isolated from the liver (30) , where sporozoites develop and differentiate after infection and found that the kinetics of activation of CD8ϩ T cells isolated from the liver is similar to that observed in the spleen ( Fig. 2A Right) .
Because activated͞memory CD8ϩ T cells may have a higher antigen-activation threshold (31-34) and therefore could display different kinetics of antigen-driven activation, we performed identical adoptive transfer experiments by using activated͞memory cells. These activated͞memory Tg CD8ϩ T cells were obtained from mice that previously received naïve Tg cells and were immunized with a recVAC (4, 19) . In these experiments, we observed that the kinetics of activation and expansion of the transferred activated͞memory CD8ϩ T cells exposed to parasite antigen were similar to those observed for naïve cells, i.e., no expansion of the CD8ϩ T cell response is observed when T cells are transferred 96 h after immunization. (Fig. 2C) . It is noteworthy that when ELISPOT was performed 16 days after transferring either activated͞memory or naïve Tg CD8ϩ T cells instead of on day four, which is the peak of the T cell response (15), the results were essentially the same; CD8ϩ T cells transferred 96 h after immunization were not activated (data not shown). These observations indicate that a low-level slowly developing T cell activation that is driven by persisting antigen does not occur.
Whereas these results suggest that functional antigen presentation occurs over a short period, they also raised the possibility that a suppressive adaptive immune response induced immediately after sporozoite immunization could be responsible for the lack of activation of CD8ϩ T cells transferred 96 h after immunization. This possibility was evaluated in experiments using RAG2 Ϫ/Ϫ mice that lack both B and T cells (35) . Along with the transfer of Tg CD8ϩ T cells at different hours after sporozoite immunization, we also reconstituted these mice with splenic CD4ϩ T cells, which are critical for the induction of the CD8ϩ T cell response (16) . Consistent with the previous results, maximum activation of the naïve Tg CD8ϩ T cells was observed when they were transferred at the same time of immunization, whereas no expansion appeared to occur when the cells were transferred after 96 h (Fig. 2D) .
Parasite Viability or Route of Immunization Does Not Modify the
Parameters of Antigen-Driven T Cell Activation. The preceding immunization experiments performed with radiation-attenuated sporozoites injected intravenously directly address the T cell response that occurs using the ''gold standard'' vaccine protocol known to induce protective immunity against malaria. However, this immunization condition may not represent the development of the immune response under normal conditions of transmission. Indeed, whereas live and attenuated sporozoites are both capable of invading hepatocytes, attenuated sporozoites undergo only limited intracellular transformations, which could limit the pool of antigen available for presentation to CD8ϩ T cells. Therefore, we tested the immunogenicity of live sporozoites to determine whether parasite viability affects the antigen-driven T cell activation. For this purpose, Tg cells were transferred into mice at different time points after immunization with live sporozoites, and their activation and expansion were assessed by ELISPOT 4 days later, at a time when mice already display incipient parasitemia. We found that mice immunized with live parasites display a pattern of antigen presentation and T cell activation identical to that observed in experiments using attenuated sporozoites (Fig. 3 A and B) .
As the natural route of sporozoite infection is through mosquito bites that inject parasites into the host skin, we also performed experiments to evaluate the kinetics of antigen-driven activation of CD8ϩ T cells when sporozoites are injected by mosquito bites. Mice were exposed to the bites of four P. yoelii-infected irradiated mosquitoes and received Tg CD8ϩ T cells at different time points after immunization. On the basis of the data available from the literature and our recent work, we estimate that a single mosquito bite injects Ϸ32-95 sporozoites (17, 18) . Four days after T cell transfer, the activation status of the Tg cells was assessed by ELISPOT. Maximum numbers of activated cells were observed when the Tg cells were transferred immediately before the exposure of mice to mosquito bites (Fig. 3C) . Again, transfer of Tg cells 96 h later resulted in negligible levels of activation comparable to control mice that did not receive Tg cells but were exposed to mosquito bites. The results obtained in the preceding experiments strongly indicate that nearly all functional antigen presentation to CD8ϩ T cells was of short duration and occurred within the first hours after immunization.
Treatment with the Antimalaria Drug Primaquine and Development of the CD8؉ T Cell Response. Previous studies have reported that treatment of immunized mice with the antimalaria drug primaquine reduced the immunity induced after immunization with sporozoites, and it was suggested that this drug could somehow interfere with antigen presentation to CD8ϩ T cells (20) . Therefore, we performed experiments to determine whether the induction of CD8ϩ T cells is affected in mice previously receiving Tg cells and treated with primaquine at different times before and after immunization (Ϫ2, 8, 24, 48, 96 h) . The activation status of the Tg cells was assessed by ELISPOT 16 days after immunization, and the results showed that CD8ϩ T cell responses were similar (Fig. 4) . However, a small decrease in the number of CD8ϩ T cells could be observed in the group of mice treated with primaquine at Ϫ2 and 8 h. It is unclear whether this marginal reduction is related to the antiparasite effect of this drug or to the toxic effect on T cells described in previous studies (36) . Nevertheless, our results clearly indicate that primaquine does not have a major effect on the induction and development of the CD8ϩ T cell response.
The Magnitude of the CD8؉ T Cell Response Is Determined by the Size of the Priming Dose and Not by the Length of Time of Antigen
Presentation. Initially, we determined that large increases in the magnitude of this CD8ϩ T cell response could be easily induced by increasing the amount of antigen used for immunization, i.e., the number of injected parasites (Fig. 5A) . Our findings indicating a short-term in vivo antigen presentation raised the intriguing possibility that an enhanced CD8ϩ T cell response could be obtained not only by increasing the antigen dose but also by artificially prolonging the length of the time of antigen presentation, by performing repeated daily immunizations. Therefore, we compared the CD8ϩ T cell response of mice that received Tg cells and were immunized with a single dose of 10 ϫ (Fig. 5B Upper) . Remarkably, however, we found that mice receiving four daily doses of 2.5 ϫ 10 4 sporozoites develop, in both the spleen and liver, a CD8ϩ T cell response comparable in magnitude to that observed in mice that received a single dose of only 2.5 ϫ 10 4 sporozoites. Similar results were obtained when the response was evaluated by FACS using SYVPSAEQI-specific tetramers (Fig. 5B Lower) . The inability to significantly increase the number of activated cells after repeated antigen exposure suggests that a state of refractoriness limits the magnitude of the immune response after the single clonal burst induced by the primary immunization.
To determine whether the failure of the CD8ϩ T cell response to expand after repeated sporozoite immunization could also occur under conditions resembling those found in malaria endemic areas, we performed experiments in which we immunized mice by repeated exposure to two bites of irradiated infected mosquitoes. For this purpose, normal mice were immunized every 48 h such that different groups of mice received a minimum of one immunization to a maximum of six. The magnitude of the CD8ϩ T cell response was determined by ELISPOT 16 days after the first immunization. A clear CD8ϩ T cell response was observed in mice after receiving two immunizations or four mosquito bites (Fig. 6) . Remarkably, however, we found no significant differences among mice receiving two, three, four, or six immunizations. Again, these results clearly indicate that once the primary T cell response becomes established at a certain level, its magnitude could not be increased despite additional exposure to antigen.
Discussion
The existence of persisting antigen and the possible role it may have in the induction and maintenance of memory CD8ϩ T cell responses remains a controversial matter for most infectious systems. The complexity of this issue is well illustrated by the apparent contradictory results obtained in viral model systems, in which the maintenance of the CD8ϩ T cell response has been described as either dependent on (23, 24, 29) or independent of (25) (26) (27) (28) 37) persisting antigen.
In this study, using Tg CD8ϩ T cells specific for a defined malaria antigen, we demonstrate that the length of time of in vivo antigen presentation, as measured by the activation of these cells, is relatively short but still generates a long-lasting antigenspecific CD8ϩ T cell response against malaria liver stages. A key finding of our study is that the antigen-driven activation of CD8ϩ T cell precursors occurs within the first 48 h. Maximum activation of CD8ϩ T cells is observed within the first 8 h after immunization, and no antigen-driven activation is observed 96 h after immunization. Although it is not possible to demonstrate the absence of antigen molecules 96 h after immunization, it is nevertheless apparent that if they exist, they have no effect on naïve or activated͞memory CD8ϩ T cells. Our results indicate that this short-term functional in vivo antigen presentation is sufficient to initiate the differentiation and proliferation processes in T cells, which lasts for several days. This is consistent with the notion that CD8ϩ T cells undergo a predefined developmental program of differentiation and clonal burst immediately after antigenic stimulation (38) (39) (40) .
The present study also revealed an intriguing phenomenon. Although it is clear that the magnitude of the primary CD8ϩ T cell response closely correlates with the number of parasites used for immunization, increasing the time of antigen presentation by daily immunizations does not enhance the magnitude of this response. These results suggest that a state of refractoriness affects the CD8ϩ T cell response immediately after priming, which becomes unresponsive to further repeated immunizations.
The inability of CD8ϩ T cells to expand further despite an increased antigen exposure during the development of the primary response is somehow reminiscent of what is observed in endemic areas where very low frequencies of T cells against liver-stage antigens are observed despite continued sporozoite inoculations through the bites of malaria-infected mosquitoes (9, 10) . Indeed, in mice, we also demonstrated that repeated bites of infected mosquitoes failed to expand the number of activated cells once a primary CD8ϩ T cell response was established. These results are of interest as this mode of immunization not only mimics the manner by which immunity to sporozoites is acquired in endemic areas, but it is also known to induce sterile immunity against Plasmodium falciparum in human volunteers (41) (42) (43) (44) .
The low frequencies of liver stage-specific CD8ϩ T cells found in endemic areas have been attributed to the existence of altered peptide ligands brought about by polymorphisms in T cell epitopes of parasite antigens (11, 12) . It has been suggested that T cell responses to liver stages can be negatively affected by antagonistic peptides that could interfere with T cell priming and the survival of memory T cells. This is definitely not the case for our findings, because we are dealing with a parasite strain with no polymorphic CD8ϩ T cell epitope. It is also possible that immune effector mechanisms, such as antibodies, can enhance the elimination of the parasites from the circulation and thus interfere with antigen processing and presentation. However, it is unlikely that such a mechanism could explain the refractoriness we observed. Under our immunization conditions, i.e., within the first 48 h, the protective immune response elicited after sporozoite immunization is mostly mediated by T cells. In fact, depletion of CD8ϩ T cells by antibody treatment results in a significant abrogation of the inhibition of liver stages (ref. 45 and data not shown).
It is intriguing that the inability of the CD8ϩ T cells to undergo further expansion contrasts with their ability to inhibit parasite development, which is detectable as early as 24 h after immunization and persists for several months (15) . Therefore, despite the relative ease in inducing primary T cell responses even with minimal parasite exposure, there seems to be strong regulatory mechanisms that inhibit the further expansion of these T cells in response to additional antigen exposure. The underlying mechanisms involved in this phenomenon of refractoriness have yet to be fully elucidated.
The results presented in this study may have practical implications for the development of vaccines aimed at inducing high numbers of long-lived memory T cells. They suggest that a short-term antigen presentation rather than an extended antigen presentation is more effective at generating maximal CD8ϩ T cell responses. Thus, the most efficient strategy for the induction of CD8ϩ T cell responses would rely on the delivery of a maximal amount of antigen in a single dose. This would ensure the induction of a single clonal burst involving the largest number of naïve CD8ϩ T cell precursors, which, following activation, differentiate and become long-lived memory cells.
